Evaluation of combined telomerase and c-myc expression in non-small cell lung carcinomas using tissue microarrays and computerized image analysis

Journal of B.U.ON.

Volumn 10, Issue 4, 2005, Pages 533-539

  Tsiambas, Evangelos ^a,e   Stamatelopoulos, A ^b   Baltayiannis, N ^b   Kandaraki, C ^c   Gerontopoulos, K ^a   Chatzimichalis, N ^b   Bouros, D ^d   Karameris, A ^a  

^a NIMTS HOSPITAL   (Greece)

^b METAXA CANCER HOSPITAL   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

^d DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^e NONE   (Greece)

Author keywords

C myc; Immunohistochemistry; Non small cell lung carcinoma; Telomerase; Tissue microarrays

Indexed keywords

MYC PROTEIN; TELOMERASE;

ADULT; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVE SITE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MALE; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TISSUE MICROARRAY;

EID: 33344476544     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Strauss GM. Prognostic markers in resectable non-small cell lung cancer. Hematol Oncol Clin North Am 1997; 11: 409-434.
2. Hammar SP, Brambilla C, Pugatch B et al. Tumours of the Lung, Pleura, Thymus and Heart. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (eds): World Health Organization Classification of Tumours, Pathology & Genetics, Lyon, IARC Press 2004, pp 26-30.
3. Wang L, Soria JC, Kemp BL, Liu DD, Mao L, Khuri FR. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer. Clin Cancer Res 2002; 8: 2883-2889.
4. Lu C, Soria JC, Tang X et al. Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers. J Clin Oncol 2004; 22: 4575-4583.
5. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43: 405-413.
6. Dhaene K, Van Marck E, Parwaresch R. Telomeres, telomerase and cancer: an up date. Virchows Arch 2000; 437: 1-16.
7. Croce CM, Thierfelder W, Erikson J et al. Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt. Proc Natl Acad Sci, USA 1983; 80: 6922-6926.
8. Leone G, Sears R, Huang E et al. Myc requires distinct E2F activities to induce S phase and apoptosis. Molec Cell 2001; 8: 105-113.
9. Wu KJ, Grandori C, Amacker M et al. Direct activation of TERT transcription by c-MYC. Nat Genet 1999; 21: 220-224.
10. Kononen J, Bubendorf L, Kallioniemi A et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844-847.
11. Simon R, Mirlacher M, Sauter G. Tissue microarrays in cancer diagnosis. Expert Rev Mol Diagn 2003; 3: 421-430.
12. Tan D, Deeb G, Wang J et al. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization. Diagn Mol Pathol 2003; 12: 201-211.
13. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
14. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (eds): World Health Organization Classification of Tumours, Pathology & Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press 2004, pp 21-23.
15. Kolquist KA, Ellisen LW, Counter CM et al. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet 1998; 19: 182-186.
16. Hiyama K, Hiyama E, Ishioka S et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995; 87: 895-902.
17. Hsu CP, Miaw J, Hsia JY, Shai SE, Chen CY. Concordant expression of the telomerase-associated genes in non small cell lung cancer. Eur J Surg Oncol 2003; 29: 594-599.
18. Sanderson SO, Sebo TJ, Murphy LM, Neumann R, Slezak J, Cheville JC. An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays. Am J Clin Pathol 2004; 121: 220-225.
19. Rubin M, Dunn R, Strawderman M, Pienta KJ. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 2002; 26: 312-319.
20. Stamatelopoulos A, Tsiambas E, Thanopoulou E, Karameris A, Vilaras G, Bouros D. Tissue microarrays in non-small cell lung carcinoma: Morphometnc study of immunohistochemical expression of topoisomerase IIa correlating with molecular detection of the specific gene alterations and chromosome 17 instability. Proc Am Soc Clin Oncol 2005; 23: 16S (abstr #873).
21. Tsiambas E, Stamatelopoulos A, Vilaras G, Thanopoulou E, Karameris A. Morphometric study of immunohistochemical expression of topoisomerase IIa and p16 correlating with molecular detection of chromosome 17 and 9 instability in pancreatic adenocarcinoma, using Tissue Microarrays application. Proc Am Soc Clin Oncol 2005; 23: 16S (abstr#332).
22. Scorilas A, Fotiou S, Tsiambas E et al. Determination of cathepsin B expression may offer additional information for ovarian cancer patients. Biol Chem 2002; 383: 1297-1303.